IRIS Accounts Production v24.2.0.383 12713739 Board of Directors 31.12.22 30.12.23 30.12.23 oncology services false true true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh127137392022-12-30127137392023-12-30127137392022-12-312023-12-30127137392021-12-30127137392021-12-312022-12-30127137392022-12-3012713739ns15:EnglandWales2022-12-312023-12-3012713739ns14:PoundSterling2022-12-312023-12-3012713739ns10:Director12022-12-312023-12-3012713739ns10:PrivateLimitedCompanyLtd2022-12-312023-12-3012713739ns10:SmallEntities2022-12-312023-12-3012713739ns10:Audited2022-12-312023-12-3012713739ns10:SmallCompaniesRegimeForDirectorsReport2022-12-312023-12-3012713739ns10:SmallCompaniesRegimeForAccounts2022-12-312023-12-3012713739ns10:FullAccounts2022-12-312023-12-3012713739ns10:OrdinaryShareClass12022-12-312023-12-3012713739ns10:Director62022-12-312023-12-3012713739ns10:Director72022-12-312023-12-3012713739ns10:CompanySecretary12022-12-312023-12-3012713739ns10:RegisteredOffice2022-12-312023-12-3012713739ns10:Director22022-12-312023-12-3012713739ns10:Director32022-12-312023-12-3012713739ns10:Director42022-12-312023-12-3012713739ns10:Director52022-12-312023-12-3012713739ns5:CurrentFinancialInstruments2023-12-3012713739ns5:CurrentFinancialInstruments2022-12-3012713739ns5:ShareCapital2023-12-3012713739ns5:ShareCapital2022-12-3012713739ns5:RetainedEarningsAccumulatedLosses2023-12-3012713739ns5:RetainedEarningsAccumulatedLosses2022-12-3012713739ns5:ShareCapital2021-12-3012713739ns5:RetainedEarningsAccumulatedLosses2021-12-3012713739ns5:RetainedEarningsAccumulatedLosses2021-12-312022-12-3012713739ns5:RetainedEarningsAccumulatedLosses2022-12-312023-12-3012713739ns5:FurnitureFittings2022-12-312023-12-3012713739ns5:ComputerEquipment2022-12-312023-12-3012713739ns5:FurnitureFittings2022-12-3012713739ns5:ComputerEquipment2022-12-3012713739ns5:FurnitureFittings2023-12-3012713739ns5:ComputerEquipment2023-12-3012713739ns5:FurnitureFittings2022-12-3012713739ns5:ComputerEquipment2022-12-3012713739ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3012713739ns5:WithinOneYearns5:CurrentFinancialInstruments2022-12-3012713739ns5:AcceleratedTaxDepreciationDeferredTax2022-12-3012713739ns5:DeferredTaxation2022-12-3012713739ns5:DeferredTaxation2022-12-312023-12-3012713739ns5:DeferredTaxation2023-12-3012713739ns10:OrdinaryShareClass12023-12-30
REGISTERED NUMBER: 12713739 (England and Wales)




REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 DECEMBER 2023

FOR

ONCACARE (U.K.) LIMITED

ONCACARE (U.K.) LIMITED (REGISTERED NUMBER: 12713739)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 30 December 2023




Page

Company Information 1

Report of the Directors 2

Report of the Independent Auditors 3

Income Statement 7

Balance Sheet 8

Statement of Changes in Equity 9

Notes to the Financial Statements 10


ONCACARE (U.K.) LIMITED

COMPANY INFORMATION
for the year ended 30 December 2023







DIRECTORS: Mr G Milborrow
Mr P F Talini
Ms T Brown





SECRETARY: Ms E Fox





REGISTERED OFFICE: 500 South Oak Way
Green Park
Reading
Berkshire
RG2 6AD





REGISTERED NUMBER: 12713739 (England and Wales)





AUDITORS: Luckmans Duckett Parker Limited
Chartered Accountants
Statutory Auditors
1110 Elliott Court
Herald Avenue
Coventry Business Park
Coventry
West Midlands
CV5 6UB

ONCACARE (U.K.) LIMITED (REGISTERED NUMBER: 12713739)

REPORT OF THE DIRECTORS
for the year ended 30 December 2023

The directors present their report with the financial statements of the company for the year ended 30 December 2023.

DIRECTORS
The directors who have held office during the period from 31 December 2022 to the date of this report are as follows:

Mr E Abdulhakim - resigned 20 April 2023
Mr G McMillan - resigned 20 April 2023
Mr K P Muthalagappan - resigned 20 April 2023
Dr U M Berger - resigned 20 April 2023
Mr G Milborrow - appointed 20 April 2023
Mr P F Talini - appointed 20 April 2023
Ms T Brown - appointed 20 April 2023

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Luckmans Duckett Parker Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Ms T Brown - Director


2 January 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ONCACARE (U.K.) LIMITED

Opinion
We have audited the financial statements of Oncacare (U.K.) Limited (the 'company') for the year ended 30 December 2023 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 December 2023 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Report of the Directors has been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ONCACARE (U.K.) LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit; or
- the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Directors.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page two, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ONCACARE (U.K.) LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to designing audit procedures by tailoring and directing testing to aid and support the determined level of risk.In response, the procedures we perform to determine the level of risk include:
- reference to history and experience of the Entity; and
- enquiry of management, including obtaining and reviewing supporting documentation concerning the
Entity's procedures relating to:

- identifying and complying with laws and regulations and whether they were aware of any instances
of non-compliance; and

- detection and response to risk of fraud and whether they were aware of any actual or suspected
instances of fraud; and
- assessment of the controls and processes that the Entity has in place to mitigate risk.

Our assessments included the identification of the following potential areas for fraud:
- management override of control; and
- revenue recognition, particularly in respect of rendering of services

These procedures, and the extent to which they are capable of detecting irregularities, including fraud, are detailed below:
- critically assessed the appropriateness and testing the application of the revenue and cost recognition
policies; and
- testing the appropriateness of accounting estimates, journals and other adjustments made in the
preparation of the financial statements; and
- reviewing the Entity's accounting policies for non-compliance with relevant standards; and
- making enquiries of management and reviewing correspondence with the relevant authorities to
identify any irregularities or instances of non-compliance with laws and regulations.

In performing an audit in accordance with UK GAAP, we exercise professional judgement and maintain professional scepticism throughout the audit process.

The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion or override of internal controls. There are inherent limitations in the audit procedures performed.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ONCACARE (U.K.) LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Mark Spafford (Senior Statutory Auditor)
for and on behalf of Luckmans Duckett Parker Limited
Chartered Accountants
Statutory Auditors
1110 Elliott Court
Herald Avenue
Coventry Business Park
Coventry
West Midlands
CV5 6UB

23 January 2025

ONCACARE (U.K.) LIMITED (REGISTERED NUMBER: 12713739)

INCOME STATEMENT
for the year ended 30 December 2023

2023 2022
£    £   

TURNOVER 2,638,404 4,282,593

Administrative expenses 2,484,711 4,052,162
OPERATING PROFIT 153,693 230,431

Interest receivable and similar income 11,142 55
PROFIT BEFORE TAXATION 164,835 230,486

Tax on profit 38,648 44,050
PROFIT FOR THE FINANCIAL YEAR 126,187 186,436

ONCACARE (U.K.) LIMITED (REGISTERED NUMBER: 12713739)

BALANCE SHEET
30 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - 20,750

CURRENT ASSETS
Debtors 5 20,982 412,127
Cash at bank and in hand 1,169,924 467,468
1,190,906 879,595
CREDITORS
Amounts falling due within one year 6 687,825 522,378
NET CURRENT ASSETS 503,081 357,217
TOTAL ASSETS LESS CURRENT
LIABILITIES

503,081

377,967

PROVISIONS FOR LIABILITIES 8 - 1,073
NET ASSETS 503,081 376,894

CAPITAL AND RESERVES
Called up share capital 9 1 1
Retained earnings 503,080 376,893
SHAREHOLDERS' FUNDS 503,081 376,894

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 2 January 2025 and were signed on its behalf by:





Ms T Brown - Director


ONCACARE (U.K.) LIMITED (REGISTERED NUMBER: 12713739)

STATEMENT OF CHANGES IN EQUITY
for the year ended 30 December 2023

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 31 December 2021 1 190,457 190,458

Changes in equity
Total comprehensive income - 186,436 186,436
Balance at 30 December 2022 1 376,893 376,894

Changes in equity
Total comprehensive income - 126,187 126,187
Balance at 30 December 2023 1 503,080 503,081

ONCACARE (U.K.) LIMITED (REGISTERED NUMBER: 12713739)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 30 December 2023

1. STATUTORY INFORMATION

Oncacare (U.K.) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Office equipment - 12.5% on cost
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

ONCACARE (U.K.) LIMITED (REGISTERED NUMBER: 12713739)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 December 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 17 (2022 - 34 ) .

4. TANGIBLE FIXED ASSETS
Office Computer
equipment equipment Totals
£    £    £   
COST
At 31 December 2022 9,742 28,735 38,477
Disposals (9,742 ) (28,735 ) (38,477 )
At 30 December 2023 - - -
DEPRECIATION
At 31 December 2022 2,693 15,034 17,727
Charge for year 1,209 6,492 7,701
Eliminated on disposal (3,902 ) (21,526 ) (25,428 )
At 30 December 2023 - - -
NET BOOK VALUE
At 30 December 2023 - - -
At 30 December 2022 7,049 13,701 20,750

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Amounts owed by group undertakings - 324,238
Other debtors - 65,328
VAT 20,471 14,966
Deferred tax asset 511 -
Prepayments and accrued income - 7,595
20,982 412,127

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 19,799 6,225
Amounts owed to group undertakings 599,543 -
Tax 40,231 40,886
Social security and other taxes 6,792 92,620
Other creditors 2,042 16,459
Accruals and deferred income 19,418 366,188
687,825 522,378

7. LEASING AGREEMENTS
At 30 December 2023, the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £Nil (2022 - £272,200).

ONCACARE (U.K.) LIMITED (REGISTERED NUMBER: 12713739)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 December 2023

8. PROVISIONS FOR LIABILITIES
2022
£   
Deferred tax
Accelerated capital allowances 5,188
Other timing differences (4,115 )
1,073

Deferred
tax
£   
Balance at 31 December 2022 1,073
Credit to Income Statement during year (1,584 )
Balance at 30 December 2023 (511 )

The deferred tax balance as at 30 December 2023 of £511 relates to the outstanding pension contributions, paid after year end of £2,042. The deferred tax provision in relation to Accelerated capital allowances reversed fully during the year, on the disposal of the companies fixed assets.

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
1 Ordinary £1 1 1

10. PENSION COMMITMENTS

The company operates a defined contribution pension scheme. At 30th December 2023 unpaid contributions of £2,042 (2022 - £16,459) were due to the fund. This is included within other creditors.

11. GROUP MEMBERSHIP

On 20 April 2023, ICON Clinical Research Limited, a company incorporated and registered in Ireland and a subsidiary of the ICON group, purchased 51% of the majority share capital of Oncacare Limited, a private company incorporated and registered in Ireland. As a result of this transaction, the Company, being a direct and wholly owned subsidiary of Oncacare Limited, became a subsidiary of the ICON group.

The Company is a wholly owned subsidiary undertaking of Oncacare Limited. The ultimate parent company of Oncacare Limited is ICON plc, a company registered in Ireland with a registered office address at South County Business Park, Leopardstown, Dublin 18, Ireland.

The largest and smallest group into which the results of the Company are consolidated is that headed by ICON plc. The consolidated financial statements may be obtained from the Companies Registration Office,Bloom House, Gloucester Place Lower, Dublin 1.